After decades of research and advocacy, the Multidisciplinary Association for Psychedelic Studies (MAPS), led by Rick Doblin, has moved into the final stages of its work pushing for MDMA-assisted psychotherapy treatment of post-traumatic stress disorder (PTSD). MAPS and the FDA have agreed on the design of the Phase III trials and, if successful, the drug could be available as a legally prescribed treatment for PTSD sufferers as soon as 2021.
.. Continue Reading Final phase trials for MDMA-assisted psychotherapy to treat PTSDCategory: Medical
Tags: Related Articles:
- Popular hair-loss drug Propecia could be linked to long-term mojo meltdown
- Drug-Free Solution from for insomnia sufferers
- Massive marijuana report reveals drug's many health effects
- Psychedelic scans show LSD’s effect on the brain for first time
- FDA ticks off first drug to treat radiation sickness after nuclear disasters
- Double-barreled drug strategy cancels cancer's backup plans
from New Atlas http://ift.tt/2wauOFN
No comments:
Post a Comment